DNase Treatment for Dry Eyes

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 11, 2017

Study Completion Date

October 11, 2017

Conditions
Dry Eye
Interventions
DRUG

DNase

DNase 0.1% eye drops four times a day for 8 weeks

DRUG

Vehicle

Drug vehicle eye drops four times a day for 8 weeks

Trial Locations (1)

60612

Translational Clinic of Corneal Neurobiology laboratory, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Research to Prevent Blindness

OTHER

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Illinois at Chicago

OTHER

NCT02193490 - DNase Treatment for Dry Eyes | Biotech Hunter | Biotech Hunter